86 related articles for article (PubMed ID: 4944363)
1. The influence of the iso-electric point of L-asparaginase upon its persistence in the blood.
Rutter DA; Wade HE
Br J Exp Pathol; 1971 Dec; 52(6):610-4. PubMed ID: 4944363
[TBL] [Abstract][Full Text] [Related]
2. Some physicochemical aspects of L-asparaginase therapy.
Mashburn LT; Landin LM
Recent Results Cancer Res; 1970; 33():48-63. PubMed ID: 4949169
[No Abstract] [Full Text] [Related]
3. [Relationship between the magnitude of Km and pH for L-asparaginase].
Libinson GS; Mikhalev AV
Biokhimiia; 1976 Jan; 41(1):149-52. PubMed ID: 6070
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
Roberts J; Schmid FA; Old LJ; Stockert E
Cancer Biochem Biophys; 1976 May; 1(4):175-8. PubMed ID: 788892
[TBL] [Abstract][Full Text] [Related]
5. The effect of chemical modification of L-asparaginase on its persistence in circulating blood of animals.
Benbough JE; Wiblin CN; Rafter TN; Lee J
Biochem Pharmacol; 1979 Mar; 28(6):833-9. PubMed ID: 110336
[No Abstract] [Full Text] [Related]
6. Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent.
Wade HE
J Gen Microbiol; 1971 Mar; 65(3):x-xi. PubMed ID: 4997395
[No Abstract] [Full Text] [Related]
7. Comparison of different techniques for isoelectric focusing on polyacrylamide gel slabs using bacterial asparaginases.
Robinson HK
Anal Biochem; 1972 Oct; 49(2):353-66. PubMed ID: 4563222
[No Abstract] [Full Text] [Related]
8. Evaluation of the embryotoxic activity of L-asparaginase.
Adamson RH; Fabro S; Hahn MA; Creech CE; Whang-Peng J
Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):310-20. PubMed ID: 4943133
[No Abstract] [Full Text] [Related]
9. The effects of immunization to L-asparaginase on antitumor and enzymatic activity.
Goldberg AI; Cooney DA; Glynn JP; Homan ER; Gaston MR; Milman HA
Cancer Res; 1973 Feb; 33(2):256-61. PubMed ID: 4569788
[No Abstract] [Full Text] [Related]
10. [Antibody sandwich enzyme-linked immunoadsorbent assay for determination of recombinant E. coli L-asparaginase in rat plasma and its pharmacokinetics].
Chen JH; Wu WT; Kazuyuki H
Yao Xue Xue Bao; 2003 Aug; 38(8):613-6. PubMed ID: 14628454
[TBL] [Abstract][Full Text] [Related]
11. L-asparaginase from Proteus vulgaris. Purification, crystallization, and enzymic properties.
Tosa T; Sano R; Yamamoto K; Nakamura M; Chibata I
Biochemistry; 1972 Jan; 11(2):217-22. PubMed ID: 4550558
[No Abstract] [Full Text] [Related]
12. A comparison of L-asparaginase from Erwinia aroideae and from Escherichia coli: biochemical and biological properties.
Staerk J; Zwisler O; Ronneberger H
Experientia; 1971 Mar; 27(3):250-2. PubMed ID: 4993733
[No Abstract] [Full Text] [Related]
13. Improvement in the therapeutic, immunological, and clearance properties of Escherichia coli and Erwinia carotovora L-asparaginases by attachment of poly-DL-alanyl peptides.
Uren JR; Ragin RC
Cancer Res; 1979 Jun; 39(6 Pt 1):1927-33. PubMed ID: 376113
[TBL] [Abstract][Full Text] [Related]
14. A simple and rapid method for the estimation of L-asparaginase in chromatographic and electrophoretic effluents: comparison with other methods.
Jayaram HN; Cooney DA; Jayaram S; Rosenblum L
Anal Biochem; 1974 Jun; 59(2):327-46. PubMed ID: 4599360
[No Abstract] [Full Text] [Related]
15. Toxic and immunodepressive effects of L-asparaginase from E. coli and from Erwinia carotovora following chronic administration in rats.
Celle G; Dodero M; Cuneo P; Picciotto A; Brambilla G; Cavanna M; Pannaciulli I
Arzneimittelforschung; 1977; 27(11):2046-50. PubMed ID: 341899
[TBL] [Abstract][Full Text] [Related]
16. Comparative experimental evaluation of immunodepressive and toxic effects of L-asparaginase (NSC-109229) from Escherichia coli and from Erwinia carotovora.
Cavanna M; Celle G; Dodero M; Picciotto A; Pannacciulli I; Brambilla G
Cancer Treat Rep; 1976 Mar; 60(3):255-7. PubMed ID: 769978
[No Abstract] [Full Text] [Related]
17. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the L-asparaginases from Escherichia coli and Erwinia carotovora as immunosuppressants.
Ashworth LA; MacLennan AP
Cancer Res; 1974 Jun; 34(6):1353-9. PubMed ID: 4596965
[No Abstract] [Full Text] [Related]
19. Modification of L-asparaginase from Erwinia carotovora using human serum albumin.
Nerkar DP; Gangadharan M
Mol Biother; 1989; 1(3):152-4. PubMed ID: 2604913
[TBL] [Abstract][Full Text] [Related]
20. A radiometric method for the measurement of L-asparaginase at concentrations below 1 X 10(-5) I.U./ml: technique and application.
Cooney DA; Milman HA; Taylor B
Biochem Med; 1976 Apr; 15(2):190-205. PubMed ID: 786281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
